Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (332,224)	$ (186,413)
Adjustments to reconcile net income to net cash (used in) provided by operating activities :
Depreciation and amortization expenses	4,425	1,858
Bad debt direct write-off and provision		11,125
Interest expense		5,742
Investment gain		(60,605)
Inventory impairment	26,012
Amortization of right-of-use assets	26,853	27,246
Loss on loan settlement		2,000
Changes in operating assets and liabilities:
Accounts receivable	57	(2)
Prepayments	(375,673)	(112,789)
Other receivables	(56,973)	101,552
Inventory	605,836	(18,762)
Other non-current assets	2,192	(24,178)
Deferred revenue	913,116	932,936
Accounts payable	(557,766)	(3,255)
Accrued liabilities and other payables	(335,374)	(18,126)
Lease liabilities	5,097	(1,714)
Net cash (used in) provided by operating activities	(74,421)	656,615
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in a subsidiary		(47,310)
Disposal of subsidiary		169,106
Purchase of property, plant and equipment	(76,941)
Net cash (used in) provided by investing activities	(76,941)	121,796
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment to related parties		(74,840)
Proceeds from related parties	158,303
Proceeds from third-party loans	164,509	50,000
Net cash provided by (used in) financing activities	322,812	(24,840)
Effect of exchange (loss)/gain on cash and cash equivalents	364	5,543
NET INCREASE IN CASH & CASH EQUIVALENTS	171,814	759,114
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	163,439	80,306
CASH & CASH EQUIVALENTS, END OF PERIOD	335,253	839,420
Supplemental Cash Flows Information:
Cash paid for interest	3,492	95
Cash paid for income tax		9
Supplemental Disclosure of Non-Cash Activities:
Common stock issued for loan settlement		$ 52,000